Guzmán-Oyarzo, D.; Hernández-Montelongo, J.; Rosas, C.; Leal, P.; Weber, H.; Alvear, M.; Salazar, L.A.
Controlled Release of Caffeic Acid and Pinocembrin by Use of nPSi-βCD Composites Improves Their Antiangiogenic Activity. Pharmaceutics 2022, 14, 484.
https://doi.org/10.3390/pharmaceutics14030484
AMA Style
Guzmán-Oyarzo D, Hernández-Montelongo J, Rosas C, Leal P, Weber H, Alvear M, Salazar LA.
Controlled Release of Caffeic Acid and Pinocembrin by Use of nPSi-βCD Composites Improves Their Antiangiogenic Activity. Pharmaceutics. 2022; 14(3):484.
https://doi.org/10.3390/pharmaceutics14030484
Chicago/Turabian Style
Guzmán-Oyarzo, Dina, Jacobo Hernández-Montelongo, Carlos Rosas, Pamela Leal, Helga Weber, Marysol Alvear, and Luis A. Salazar.
2022. "Controlled Release of Caffeic Acid and Pinocembrin by Use of nPSi-βCD Composites Improves Their Antiangiogenic Activity" Pharmaceutics 14, no. 3: 484.
https://doi.org/10.3390/pharmaceutics14030484
APA Style
Guzmán-Oyarzo, D., Hernández-Montelongo, J., Rosas, C., Leal, P., Weber, H., Alvear, M., & Salazar, L. A.
(2022). Controlled Release of Caffeic Acid and Pinocembrin by Use of nPSi-βCD Composites Improves Their Antiangiogenic Activity. Pharmaceutics, 14(3), 484.
https://doi.org/10.3390/pharmaceutics14030484